154 related articles for article (PubMed ID: 12548157)
1. High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma.
Schoemaker NE; Rosing H; Jansen S; Schellens JH; Beijnen JH
Ther Drug Monit; 2003 Feb; 25(1):120-4. PubMed ID: 12548157
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of carboxylate and lactone forms of irinotecan and three metabolites in human plasma.
Owens TS; Dodds H; Fricke K; Hanna SK; Crews KR
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):65-74. PubMed ID: 12668072
[TBL] [Abstract][Full Text] [Related]
3. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
de Bruijn P; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):277-85. PubMed ID: 9367218
[TBL] [Abstract][Full Text] [Related]
4. Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma.
Rivory LP; Robert J
J Chromatogr B Biomed Appl; 1994 Nov; 661(1):133-41. PubMed ID: 7866541
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat.
Yang X; Hu Z; Chan SY; Goh BC; Duan W; Chan E; Zhou S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(2):221-8. PubMed ID: 15936253
[TBL] [Abstract][Full Text] [Related]
6. Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies.
Escoriaza J; Aldaz A; Castellanos C; Calvo E; Giráldez J
J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):159-68. PubMed ID: 10821401
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of the lactone and carboxylate forms of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in rat plasma by high performance liquid chromatography.
Kaneda N; Hosokawa Y; Yokokura T
Biol Pharm Bull; 1997 Jul; 20(7):815-9. PubMed ID: 9255427
[TBL] [Abstract][Full Text] [Related]
8. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
Park DJ; Won JH; Cho AR; Yun HJ; Heo JH; Hwhang TH; Lee DH; Kim WM
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():147-152. PubMed ID: 24927278
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatographic-tandem mass spectrometric assay for the simultaneous quantification of Camptosar and its metabolite SN-38 in mouse plasma and tissues.
Bardin S; Guo W; Johnson JL; Khan S; Ahmad A; Duggan JX; Ayoub J; Ahmad I
J Chromatogr A; 2005 May; 1073(1-2):249-55. PubMed ID: 15909526
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
Talanta; 2008 Sep; 76(5):1015-21. PubMed ID: 18761148
[TBL] [Abstract][Full Text] [Related]
11. Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry.
Ragot S; Marquet P; Lachâtre F; Rousseau A; Lacassie E; Gaulier JM; Dupuy JL; Lachâtre G
J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):175-84. PubMed ID: 10676997
[TBL] [Abstract][Full Text] [Related]
12. Determination of irinotecan (CPT-11) and SN-38 in human whole blood and red blood cells by liquid chromatography with fluorescence detection.
de Jong FA; Mathijssen RH; de Bruijn P; Loos WJ; Verweij J; Sparreboom A
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 795(2):383-8. PubMed ID: 14522044
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of the lactone and carboxylate forms of the camptothecin derivative CPT-11 and its metabolite SN-38 in plasma by high-performance liquid chromatography.
Chollet DF; Goumaz L; Renard A; Montay G; Vernillet L; Arnera V; Mazzo DJ
J Chromatogr B Biomed Sci Appl; 1998 Oct; 718(1):163-75. PubMed ID: 9832373
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic determination of irinotecan (CPT-11) and its active metabolite (SN-38) in human plasma.
Sumiyoshi H; Fujiwara Y; Ohune T; Yamaoka N; Tamura K; Yamakido M
J Chromatogr B Biomed Appl; 1995 Aug; 670(2):309-16. PubMed ID: 8548021
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma.
Rosing H; Doyle E; Davies BE; Beijnen JH
J Chromatogr B Biomed Appl; 1995 Jun; 668(1):107-15. PubMed ID: 7550966
[TBL] [Abstract][Full Text] [Related]
16. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Puangpetch A; Prommas S; Sirilerttrakul S; Rerkarmnuaychoke B; Wongwaisayawan S; Sukasem C
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28393405
[TBL] [Abstract][Full Text] [Related]
17. Trace analysis of SN-38 in human plasma by high-performance liquid chromatography.
Rivory LP; Findlay M; Clarke S; Bishop J
J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):355-9. PubMed ID: 9766876
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT.
Kurita A; Kaneda N
J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(2):335-44. PubMed ID: 10219676
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients.
Barilero I; Gandia D; Armand JP; Mathieu-Boué A; Ré M; Gouyette A; Chabot GG
J Chromatogr; 1992 Mar; 575(2):275-80. PubMed ID: 1629304
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
